Date of Award
Campus Access Thesis
Master of Science (MS)
Alzheimer’s disease (AD) is the most common neurodegenerative disorder characterized by progressive deterioration of memory and cognition. Several factors, such as the formation of amyloid-β (Aβ) deposits, oxidative stress and low level of the neurotransmitter acetylcholine (ACh) play major roles in the pathophysiology of the disease. The cholinergic hypothesis of AD suggests that dysfunction in learning and memory is due to the low levels of ACh in specific regions of the AD affected brain. The concentration of ACh can be increased by inhibiting the metabolic enzymes acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE). The goal of my work was to explore the fundamentals of multifunctional anti-Alzheimer’s compounds. We designed and synthesized novel molecules that can effectively inhibit the activity of the cholinesterases and at the same time interfere with other key processes that contribute to the development of Alzheimer’s disease, such as amyloid self-assembly and oxidative stress. We designed and tested about 120 compounds with several core structures, including β-carbolines, sulfonamides, chalcones, coumarines and hydrazones. These molecules were evaluated by standard in vitrobiochemical assays for their ability to inhibit cholinesterase enzymes and Aβ selfassembly, to disassemble preformed Aβ aggregates and to scavenge free radicals. The validation of the binding mechanism in AChE inhibition was carried out in silicousing molecular docking. Some of the tested compounds exhibited promising effects in the enzyme activity measurements and self-assembly studies and were also excellent free radicals scavengers. Therefore these molecules could be promising scaffolds for the further development of multifunctional therapeutics for Alzheimer's disease.
Tulsan, Rekha, "Development of Multifunctional Anti-Alzheimer's Compounds" (2012). Graduate Masters Theses. 134.